US Broker Ratings

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 13.64% Potential Upside for Investors

HealthStream, Inc. (NASDAQ: HSTM), a key player in the healthcare information services sector, is gaining notable attention from investors due to its promising growth metrics and..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Growth with a 15.56% ROE

As the healthcare sector continues to evolve, AMN Healthcare Services Inc. (NYSE: AMN) stands out for its comprehensive suite of technology-enabled workforce solutions and staffing services...

ArriVent BioPharma, Inc. (AVBP)

⚠️ No article content returned.

..

Immunome, Inc. (IMNM) Stock Analysis: Exploring a 68.50% Potential Upside in the Biotech Sector

Immunome, Inc. (NASDAQ: IMNM) stands out in the biotechnology sector with an impressive market capitalization of $2.37 billion. As a specialized player in oncology therapeutics, the..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 36% Potential Upside in Healthcare

InnovAge Holding Corp. (NASDAQ: INNV) presents an intriguing opportunity for investors looking to tap into the healthcare sector, particularly in the niche of medical care facilities...

Investor Outlook: GH Research PLC (GHRS) Poised for 87.62% Upside with Promising Phase 2 Trials

GH Research PLC (NASDAQ: GHRS), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising clinical pipeline and substantial potential upside. Headquartered..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a 55% Upside in the Medical Devices Arena

Delcath Systems, Inc. (NASDAQ: DCTH) is drawing significant attention in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $534.71 million,..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Unpacking the 174% Potential Upside

Taysha Gene Therapies, Inc. (TSHA), a clinical-stage biotechnology company, has been the subject of significant investor interest due to its promising pipeline and compelling analyst ratings...

Embecta Corp. (EMBC): Investor Outlook Amidst Potential Downside and Strategic Positioning

Embecta Corp. (NASDAQ: EMBC) finds itself at a pivotal moment as it navigates the challenging waters of the healthcare sector. With a market cap of $328.06..

STAAR Surgical Company (STAA) Stock Analysis: Unveiling a 23.77% Potential Upside in the Healthcare Sector

Investors in the healthcare sector may find STAAR Surgical Company (NASDAQ: STAA) a compelling opportunity as it continues to make strides in the medical instruments and..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Contender with 33.68% Potential Upside

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a burgeoning player in the biotech sector, is capturing investor attention with its promising portfolio in the treatment of inflammatory diseases...

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring the Growth Potential in Biotech Innovations

Anavex Life Sciences Corp. (NASDAQ: AVXL), a promising player in the biotechnology sector, has been attracting attention with its innovative approach to treating central nervous system..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating a Challenging Market with Solid Software Solutions

Simulations Plus, Inc. (NASDAQ: SLP) stands at the intersection of healthcare innovation and advanced technology, serving as a pivotal player in the Health Information Services industry...

Akebia Therapeutics (AKBA) Stock Analysis: Exploring a Potential 349% Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA) stands at a pivotal point in its journey as a specialty and generic drug manufacturer within the healthcare sector. Known for..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Gem with 116.80% Potential Upside

Savara, Inc. (NASDAQ: SVRA) stands out in the healthcare sector as a promising biopharmaceutical company focused on rare respiratory diseases. With a market capitalization of $1.03..

Beta Bionics, Inc. (BBNX): Investor Outlook Reveals 23.39% Potential Upside

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the healthcare sector with its innovative approach to diabetes management. As a commercial-stage medical device company, Beta..

Zymeworks Inc. (ZYME) Stock Analysis: Biotech Innovator with a 58% Upside Potential

Zymeworks Inc. (NASDAQ: ZYME), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising pipeline of biotherapeutics targeting cancer, inflammation, and..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a 133.81% Potential Upside in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB) stands out in the biotechnology sector as a company with promising momentum in cancer treatment development. Founded in 2018 and headquartered..

Replimune Group, Inc. (REPL) Stock Analysis: Biotechnology Leader with Nearly 45% Upside Potential

Replimune Group, Inc. (NASDAQ: REPL) is a notable player in the biotechnology sector, specializing in cutting-edge oncolytic immunotherapies aimed at treating cancer. With a market capitalization..

CareDx, Inc. (CDNA) Stock Analysis: A Healthcare Marvel with a Robust Revenue Growth

CareDx, Inc. (NASDAQ: CDNA), a significant player in the diagnostics and research sector within the healthcare industry, has been capturing investor attention with its impressive revenue..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds